NewAmsterdam Pharma, a biopharmaceutical company developing treatments for cardiovascular disease, announced its participation in three upcoming investor conferences in November 2026: Guggenheim Healthcare Innovation Conference, Stifel Healthcare Conference, and Jefferies Global Healthcare Conference. Company executives will engage in fireside chats to discuss their late-stage clinical programs, including their oral CETP inhibitor obicetrapib aimed at lowering LDL cholesterol. These events provide opportunities for investors to learn about NewAmsterdam's progress and strategy in addressing cardiovascular risk with new therapies. Live webcasts and replays will be available on the company's investor relations website.
NewAmsterdam Pharma's upcoming participation in investor conferences is contextually set against a health sector where 75 of 150 US stocks rose and 69 fell on Pluang today. Notable movers include Koninklijke Philips NV (PHG) at USD 29.00 with a 5.11% increase, Nuvation Bio Inc. Class A (NUVB) at USD 4.81 up 4.79%, and Aurora Cannabis Inc (ACB) at USD 4.38 with a 3.79% rise. This data is current as of Nov 03, 2026 20:11 WIB.
The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
